Thomas Cahill Transaction History

Date Transaction Value Shares Traded Form
Oct 24 2022
BUY
Open market or private purchase
$6,800,000 $17.0 p/Share
400,000
Oct 24 2022
BUY
Conversion of derivative security
-
4,905,679
TC

Thomas Cahill

Director
Cambridge, MA

Track Institutional and Insider Activities on PRME

Follow Prime Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRME shares.

Notify only if

Insider Trading

Get notified when an Prime Medicine, Inc. insider buys or sells PRME shares.

Notify only if

News

Receive news related to Prime Medicine, Inc.

Track Activities on PRME